Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...
Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...
Representing 58.4% of Total RevenueStrong Q3 Profitability: 9.0% Net Income margin and 32.8% Adjusted EBITDA marginUpdates 2025 Revenue and Adjusted EBITDA GuidanceFinalizes Strategic Partnerships to ...
The company is seeing rapid growth in its operations, expanded customer activity, and as a stable financial position heading ...
Varying the format of comprehension checks guides students to demonstrate learning and provides teachers feedback on progress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback